Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 25,000 shares at $50.00 ($1.3M) on 2020-09-29, disclosed to the SEC on 2020-10-01.
Open-market sale of $1.2M ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |